Subcutaneous Immunoglobulin Replacement Following CD19-Specific Chimeric Antigen Receptor-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Subcutaneous Immunoglobulin ◽

T Cell Therapy ◽

Cell Acute Lymphoblastic Leukemia ◽

Immunoglobulin Replacement

Subcutaneous immunoglobulin replacement following CD19‐specific chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia in pediatric patients

Pediatric Blood & Cancer ◽

10.1002/pbc.28092 ◽

2019 ◽

Vol 67 (3) ◽

Author(s):

Danielle E. Arnold ◽

Shannon L. Maude ◽

Colleen A. Callahan ◽

Amanda M. DiNofia ◽

Stephan A. Grupp ◽

...

Keyword(s):

Cell Therapy ◽

B Cell ◽

Pediatric Patients ◽

Lymphoblastic Leukemia ◽

Subcutaneous Immunoglobulin ◽

T Cell Therapy ◽

Cell Acute Lymphoblastic Leukemia ◽

Immunoglobulin Replacement

Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia

The Cancer Journal ◽

10.1097/ppo.0000000000000508 ◽

2021 ◽

Vol 27 (2) ◽

pp. 98-106

Author(s):

Jordan Gauthier ◽

Cameron J. Turtle

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22 T Cell Therapy in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

SSRN Electronic Journal ◽

10.2139/ssrn.3421605 ◽

2019 ◽

Author(s):

Hanren Dai ◽

Zhiqiang Wu ◽

Hejin Jia ◽

Chuan Tong ◽

Yelei Guo ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Receptor Targeting ◽

T Cell Therapy ◽

Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia

Chinese Medical Journal ◽

10.1097/cm9.0000000000000638 ◽

2020 ◽

Vol 133 (4) ◽

pp. 474-482

Author(s):

Xian Zhang ◽

Jing-Jing Li ◽

Pei-Hua Lu

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Improving and Maintaining Responses in Pediatric B–Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor–T Cell Therapy

The Cancer Journal ◽

10.1097/ppo.0000000000000513 ◽

2021 ◽

Vol 27 (2) ◽

pp. 151-158

Author(s):

Rahul Arya ◽

David M. Barrett ◽

Stephan A. Grupp ◽

Jan Joseph Melenhorst

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia

Expert Review of Clinical Immunology ◽

10.1080/1744666x.2021.1828067 ◽

2020 ◽

Vol 16 (10) ◽

pp. 1029-1042

Author(s):

Regina M. Myers ◽

Joseph Dolan ◽

David T. Teachey

Keyword(s):

T Cell ◽

Young Adult ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

PS962 PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere ◽

10.1097/01.hs9.0000562152.07779.48 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 433 ◽

Cited By ~ 3

Author(s):

A.S. Wayne ◽

V. Huynh ◽

N. Hijiya ◽

R. Rouce ◽

P.A. Brown ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Phase 1 ◽

Antigen Receptor ◽

T Cell Therapy ◽

Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view

European Journal Of Haematology ◽

10.1111/ejh.13427 ◽

2020 ◽

Vol 105 (2) ◽

pp. 203-215 ◽

Cited By ~ 2

Author(s):

Frederick W. Thielen ◽

Annemieke Dongen‐Leunis ◽

Alexander M. M. Arons ◽

Judith R. Ladestein ◽

Peter M. Hoogerbrugge ◽

...

Keyword(s):

Cost Effectiveness ◽

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Abstract A11: A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapy

10.1158/1538-7445.pedca19-a11 ◽

2020 ◽

Author(s):

Katherine E. Masih ◽

Rebecca Gardner ◽

Berkley E. Gryder ◽

Abdalla Abdelmaksoud ◽

Ashley Wilson ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T ◽

766. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Molecular Therapy ◽

10.1016/s1525-0016(16)35779-3 ◽

2014 ◽

Vol 22 ◽

pp. S295-S296 ◽

Cited By ~ 2

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T ◽